PCM
NGVT icon

Prelude Capital Management’s Ingevity NGVT Stock Holding History

Prelude Capital Management’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,203
Closed -$206K – 1235
2025
Q1 		$206K Buy
+5,203
New +$230K 0.02% 929
2023
Q1 		– Sell
-3,209
Closed -$226K – 1366
2022
Q4 		$226K Buy
+3,209
New +$226K 0.01% 917
2020
Q4 		– Sell
-1,751
Closed -$87K – 1749
2020
Q3 		$87K Sell
1,751
-4,732
-73% -$267K ﹤0.01% 958
2020
Q2 		$341K Buy
6,483
+924
+17% +$43.9K 0.02% 587
2020
Q1 		$196K Buy
5,559
+3,004
+118% +$175K 0.01% 453
2019
Q4 		$223K Buy
2,555
+2,472
+2,978% +$216K 0.01% 825
2019
Q3 		$7K Sell
83
-1,158
-93% -$103K ﹤0.01% 1530
2019
Q2 		$131K Buy
1,241
+151
+14% +$15.2K 0.01% 858
2019
Q1 		$115K Sell
1,090
-710
-39% -$71.3K 0.01% 885
2018
Q4 		$151K Buy
+1,800
New +$163K 0.01% 818

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Prelude Capital Management's NGVT Position: Q2 2025 in Review

Prelude Capital Management sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 5,203 shares — an estimated $206K sold.

Prelude Capital Management first reported a position in NGVT in Q4 2018 and held it in 10 quarters. The position peaked at $341K in Q2 2020. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

  • Prelude Capital Management reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 5,203 Ingevity shares in Q2 2025, an estimated $206K.
  • Prelude Capital Management first reported a position in Ingevity in Q4 2018 and held it in 10 quarters.
  • Prelude Capital Management's Ingevity position peaked at $341K in Q2 2020.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.